Cutaneous reactions during treatment with Nifurtimox or Benznidazole among <i>Trypanosoma cruzi</i> seropositive adults without symptomatic cardiomyopathy: A safety sub analysis of a placebo‐controlled randomised trial
CARDT occurred more frequently with Benznidazole treatment, particularly with longer exposure despite the half-dose regimen. Clinicians should consider these differences when discussing treatment options with patients receiving nitro derivative agents.
Authors
- H. Arango (ORCID: https://orcid.org/0009-0004-1807-1867)
- María Fernanda Saavedra-Chacón (ORCID: https://orcid.org/0000-0003-1191-4361)
- Mario Javier Olivera (ORCID: https://orcid.org/0000-0002-6885-6353)
- Eliana Váquiro Herrera (ORCID: https://orcid.org/0000-0001-6030-8128)
- Juan Carlos Villar (ORCID: https://orcid.org/0000-0002-7047-7299)
- Skarlet Marcell Vásquez (ORCID: https://orcid.org/0000-0003-2552-9819)
- A. A. Camacho
Institutions
- Universidad Autónoma de Bucaramanga (CO)
- Institute of Cardiology (CO)
- Clínica CES (CO)
- Instituto Nacional de Salud (CO)
- Universidad del Rosario (CO)
Publication Details
- Journal
- Tropical Medicine & International Health
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1111/tmi.14123
- Citations
- 2
- Primary Topic
- Trypanosoma species research and implications
- Type
- article
- Field-Weighted Citation Impact
- 2.71